IC
HOLX

Innealta Capital’s Hologic HOLX Stock Holding History

Innealta Capital’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-337
Closed -$25K – 833
2024
Q2 		$25K Buy
+337
New +$25.3K 0.01% 575

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Innealta Capital's HOLX Position: Q3 2024 in Review

Innealta Capital sold out of Hologic (HOLX) in Q3 2024, closing a stake of 337 shares — an estimated $25K sold.

Innealta Capital first reported a position in HOLX in Q2 2024 and held it in 1 quarter. The position peaked at $25K in Q2 2024. 727 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

  • Innealta Capital reported no remaining Hologic position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 337 Hologic shares in Q3 2024, an estimated $25K.
  • Innealta Capital first reported a position in Hologic in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's Hologic position peaked at $25K in Q2 2024.
  • 727 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.